Technology

MeyerZall's focus in the last 24 months has been concentrated in three areas:

• To enhance its technology.

• To enhance the applicability to disease therapy

• To optimise the applicable mode of drug administration.

Research has confirmed the following key characteristics of this unique therapeutic system:

• Decreased time to onset of action

It has been repeatedly indicated that the Emzaloid™ rapidly traverses most physiological barriers and delivers the active significantly quicker to the point of action than that same active delivered via a conventional approach, suggesting faster relief from target symptoms.